Pedicularis resupinata Extract Prevents Depressive-like Behavior in Repeated Corticosterone-Induced Depression in Mice: A Preliminary Study.
Dong Wook LimDaeseok HanChang-Ho LeePublished in: Molecules (Basel, Switzerland) (2022)
Excessive corticosterone (CORT), resulting from a dysregulated hypothalamic-pituitary-adrenal (HPA) axis, is associated with cognitive impairment and behavioral changes, including depression. In Korean oriental medicine, Pedicularis resupinata is used for the treatment of inflammatory diseases such as rheumatoid arthritis. However, the antidepressant properties of P. resupinata have not been well characterized. Here, the antidepressant-like effects of P. resupinata extract (PRE) were evaluated in terms of CORT-induced depression using in vivo models. HPLC confirmed that acteoside, a phenylethanoid glycoside, was the main compound from PRE. Male ICR mice (8 weeks old) were injected with CORT (40 mg/kg, i.p.) and orally administered PRE daily (30, 100, and 300 mg/kg) for 21 consecutive days. Depressive-like behaviors were evaluated using the open-field test, sucrose preference test, passive avoidance test, tail suspension test, and forced swim test. Treatment with a high dose of PRE significantly alleviated CORT-induced, depressive-like behaviors in mice. Additionally, repeated CORT injection markedly reduced brain-derived neurotrophic factor levels, whereas total glucocorticoid receptor (GR) and GR phosphorylation at serine 211 were significantly increased in the mice hippocampus but improved by PRE treatment. Thus, our findings suggest that PRE has potential antidepressant-like effects in CORT-induced, depressive-like behavior in mice.
Keyphrases
- high glucose
- high fat diet induced
- diabetic rats
- bipolar disorder
- rheumatoid arthritis
- high dose
- major depressive disorder
- cognitive impairment
- depressive symptoms
- stress induced
- drug induced
- type diabetes
- low dose
- endothelial cells
- insulin resistance
- metabolic syndrome
- mass spectrometry
- disease activity
- ms ms
- combination therapy
- risk assessment
- wild type
- high resolution
- protein kinase
- ankylosing spondylitis
- systemic lupus erythematosus
- stem cell transplantation
- adipose tissue
- tandem mass spectrometry
- human health
- liquid chromatography
- interstitial lung disease